Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nakarani, A.
7  Ergebnisse:
Personensuche X
?
1

Solubilization study of antihypertensive drug Irbesartan in..:

Kadam, Y. ; Savle, A. ; Nakarani, A...
Colloids and Surfaces A: Physicochemical and Engineering Aspects.  693 (2024)  - p. 134024 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Antiosteoporotic effect of Hemidesmus indicus Linn. on ovar..:

Desai, Sharad ; Babaria, Parth ; Nakarani, Madhavi..
Journal of Ethnopharmacology.  199 (2017)  - p. 1-8 , 2017
Link: https://doi.org/10.1016/..
 
?
3

Cyclosporine A-Nanosuspension: Formulation, Characterizatio..:

Nakarani, Mahendra
Scientia Pharmaceutica.  78 (2010)  2 - p. 345-361 , 2010
Link: https://doi.org/10.3797/..
 
?
4

Nutritional and phytochemical profiling of nutracereal fing..:

Nakarani, Udit M. ; Singh, Diwakar ; Suthar, Kiran P....
Food Chemistry.  341 (2021)  - p. 128271 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Estimation of Atorvastatin Calcium and Fenofibrate in Table..:

Nakarani, Naresh V ; Bhatt, Kashyap K ; Patel, Rutva D.
Journal of AOAC INTERNATIONAL.  90 (2007)  3 - p. 700-705 , 2007
Link: https://doi.org/10.1093/..
 
?
6

Itraconazole nanosuspension for oral delivery: Formulation,..:

Nakarani, M ; Misra, A.K ; Patel, J.K.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304368.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
7

Cyclosporine A-Nanosuspension: Formulation, Characterizatio..:

Mahendra NAKARANI ; Priyal PATEL ; Jayvadan PATEL...
https://dx.doi.org/10.3797/scipharm.0908-12.  , 2010
Link: https://doi.org/10.3797/..
 
1-7